CMPS insider trading
NasdaqGS HealthcareCOMPASS Pathways plc — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About COMPASS Pathways plc
COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. The company was incorporated in 2020 and is headquartered in London, the United Kingdom.
Company website: compasspathways.com
CMPS insider activity at a glance
FilingIQ has scored 161 insider transactions for CMPS since Feb 1, 2022. The most recent filing in our index is dated Mar 26, 2026.
Across the full history, 0 open-market purchases
and 91 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on CMPS insider trades is 56.2/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for CMPS?
- FilingIQ tracks 161 Form 4 insider transactions for CMPS (COMPASS Pathways plc), covering filings from Feb 1, 2022 onwards. 9 of those were filed in the last 90 days.
- Are CMPS insiders net buyers or net sellers?
- Across the full Form 4 history for CMPS, 0 transactions (0%) were open-market purchases and 91 (57%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does CMPS insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is CMPS in?
- COMPASS Pathways plc (CMPS) is classified in the Healthcare sector, specifically Medical Care Facilities, with a current market capitalisation of $692.32M.
Methodology & sources
Every CMPS insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.